Speakers

Rammohan Devulapally is a scientific leader with more than 20 years of experience advancing non-viral delivery technologies for genetic medicines. As Senior Director and Head of Non-Viral Delivery at Granza Bio, he leads the development of targeted lipid nanoparticle platforms for immune cell-specific delivery and next-generation immunotherapies. Previously, he held leadership roles at Life Edit Therapeutics, GenEdit/Breeze Bio, ReCode Therapeutics, and Stanford University. His expertise spans lipid discovery, nanoparticle engineering, targeted delivery, CMC, and translational development, supporting innovative therapies across oncology, immunology, rare diseases, and multiple nucleic acid modalities.